Can a cortisol‑producing adrenal tumor cause secondary (functional) hypothyroidism?

Can Adrenal Tumors Cause Elevated Cortisol and Hypothyroidism?

Yes, cortisol-producing adrenal tumors can cause secondary (functional) hypothyroidism through direct suppression of the hypothalamic-pituitary-thyroid axis by excess glucocorticoids—a condition termed "corticogenic hypothyroidism." 1, 2

Mechanism of Corticogenic Hypothyroidism

Excess cortisol from an adrenal adenoma suppresses TSH secretion primarily at the pituitary level, resulting in low T4 and T3 concentrations despite normal or low-normal TSH levels. 1, 2 This represents a functional form of central hypothyroidism caused by glucocorticoid excess rather than intrinsic pituitary or hypothalamic disease.

Key Diagnostic Features

• Biochemical pattern: Markedly diminished serum T4 and T3, with basal TSH levels that are not elevated and show blunted or absent response to TRH stimulation. 1
• ACTH suppression: In adrenal Cushing's syndrome, ACTH is always low or undetectable (<5 pg/mL), confirming an ACTH-independent source. 3
• Reversibility: Serum T4 and T3 normalize when hypercortisolism is corrected after adrenalectomy, confirming the cortisol-mediated mechanism. 1, 2

Diagnostic Algorithm for Suspected Adrenal Cushing's with Hypothyroidism

Step 1: Confirm Autonomous Cortisol Secretion

• Perform 1 mg overnight dexamethasone suppression test; serum cortisol >138 nmol/L (>5.0 mg/dL) indicates autonomous cortisol secretion. 4
• Measure 24-hour urinary free cortisol to quantify hypercortisolism severity. 5
• Obtain morning ACTH level (08:00-09:00h); ACTH <5 pg/mL or undetectable confirms ACTH-independent (adrenal) Cushing's syndrome. 3, 4

Step 2: Characterize the Adrenal Mass

• Obtain unenhanced CT to assess Hounsfield units (<10 HU suggests benign adenoma) and measure tumor size. 4
• Screen for pheochromocytoma with plasma free metanephrines or 24-hour urinary fractionated metanephrines before any intervention. 4
• If tumor >4 cm, heterogeneous, or shows invasion/necrosis, consider adrenocortical carcinoma and plan open adrenalectomy. 6, 5

Step 3: Assess Thyroid Function

• Measure free T4, free T3, and TSH to document the degree of hypothyroidism. 1
• Perform TRH stimulation test; absent or blunted TSH response confirms corticogenic hypothyroidism rather than primary thyroid disease. 1, 2
• Do not initiate thyroid hormone replacement before adrenalectomy, as correction of hypercortisolism typically restores normal thyroid function. 1

Step 4: Screen for Cortisol-Related Comorbidities

• Hypertension, type 2 diabetes, and osteoporosis/vertebral fractures are common and should be documented. 4
• Obtain echocardiogram if severe hypercortisolism is suspected to assess for left ventricular hypertrophy. 4

Treatment Approach

Surgical Management

• Laparoscopic adrenalectomy is the treatment of choice for benign cortisol-secreting adenomas causing symptomatic hypercortisolism and corticogenic hypothyroidism. 4, 5
• Open adrenalectomy is indicated for masses >4 cm with features concerning for malignancy. 6, 5
• Bilateral adrenalectomy should be reserved for severe, refractory Cushing's syndrome with life-threatening complications requiring rapid cortisol normalization. 7, 4

Post-Operative Considerations

• Temporary glucocorticoid replacement is mandatory after unilateral adrenalectomy due to suppression of the contralateral adrenal gland. 4, 8
• Monitor cortisol response to ACTH stimulation; recovery of the hypothalamic-pituitary-adrenal axis typically occurs within 2 months but may take longer. 8
• Thyroid function normalizes spontaneously after correction of hypercortisolism; repeat thyroid function tests 4-6 weeks post-operatively to confirm resolution. 1, 2

Important Clinical Pitfalls

Avoid Premature Thyroid Hormone Replacement

Starting levothyroxine before adrenalectomy is unnecessary and may complicate post-operative management, as thyroid function recovers once cortisol excess is eliminated. 1, 2

Recognize Subclinical Autonomous Cortisol Secretion

Even adenomas with cortisol levels <140 nmol/L after dexamethasone may demonstrate HPA axis suppression through other measures (decreased DHEAS, abnormal adrenal scintigraphy), increasing the risk of post-operative adrenal insufficiency. 8

Monitor for Post-Operative Hypercalcemia

Glucocorticoid deficiency after adrenalectomy can cause hypercalcemia through increased bone resorption, particularly when combined with restoration of normal TSH secretion. 2 Close monitoring of calcium levels and adequate glucocorticoid replacement prevents this complication.

Distinguish from Bilateral Disease

Measure 17-hydroxyprogesterone in all patients with bilateral adrenal masses to exclude congenital adrenal hyperplasia, which requires different management. 4